Skip to content

Author

Shengnan She

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Nucleoside-modified circRNA: Reduced immunogenicity and expansive applications beyond vaccines

mRNA drives the production of functional proteins to achieve therapeutic intervention, rendering it an attractive molecular platform for biomedical applications. In the 1990s, researchers established in vitro transcription (IVT) systems to produce linear mRNA encoding target proteins. Neverthe-less, unmodified mRNA exh...

Xin-Yue Wang, Sheng-Nan She, Chi Zhang et al. · 0 citations
Open access Jul 2026

IVT-free, chemically synthesized protein-encoding RNA oligonucleotides for rapid production of personalized cancer vaccines

Significance Personalized mRNA cancer vaccines hold great therapeutic promise, yet their production depends on multistep in vitro transcription (IVT) that generates immunogenic dsRNA impurities and prolongs manufacturing to nearly three months, often missing the optimal therapeutic window. Here, we introduced a cap-ind...

Qian Pan, Chi Zhang, Xinyue Wang et al. · 0 citations
Open access Aug 2026

Artificial Intelligence-Guided Prioritization and Experimental Evaluation of Synergistic Target Combinations for Breast Cancer Therapy

The BIRC5-NAMPT-TOP1 combination showed reproducible phenotypic activity in the tested genetic and pharmacological models and support the use of DeepMDS as a hypothesis-generation tool for higher-order target prioritization.

Chun-Lai Feng, Qiuqi Feng, Sheng-Nan She et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.